Continuity Biosciences
PrivateLast Round
Series A
Aug 19, 2025
Total Funding Raised
$14.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Continuity Biosciences is a biotechnology company developing implantable and device-enabled platform technologies for cell reprogramming, immune modulation, and precision drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Continuity Biosciences Comparables
Compare Continuity Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Persista Bio Inc. | 78% | |
| TheraCyte, Inc. | 77% | |
| Encellin | 76% | |
Continuity Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 19, 2025 | ||||
| Seed | Jun 4, 2025 | ||||
| Seed | Jun 18, 2024 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 387% MoM.
- Jun 30, 2026
Grew 21% QoQ from 19 to 23 employees.
Continuity Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Continuity Biosciences's valuation, stock price, and market status.